PTEN–GSK3β–MOB1 axis controls neurite outgrowth in vitro and in vivo

被引:0
|
作者
Zhiwen Song
Xiu Han
Hongjun Zou
Bin Zhang
Ya Ding
Xu Xu
Jian Zeng
Jinbo Liu
Aihua Gong
机构
[1] The Third Affiliated Hospital of Soochow University,Department of Orthopaedics, School of Medicine
[2] Jiangsu University,Department of Cell Biology, School of Medicine
[3] Affiliated Hospital of Jining Medical University,Department of Laboratory Medicine
来源
关键词
MOB1; PTEN; GSK3β; Neurite outgrowth; Spinal cord injury;
D O I
暂无
中图分类号
学科分类号
摘要
Mps One binder 1 (MOB1) is a core component of NDR/LATS kinase and a positive regulator of the Hippo signaling pathway. However, its role in neurite outgrowth still remains to be clarified. Here, we confirmed, for the first time, that MOB1 promoted neurite outgrowth and was involved in functional recovery after spinal cord injury (SCI) in mice. Mechanistically, we found that MOB1 stability was regulated by the PTEN–GSK3β axis. The MOB1 protein was significantly up-regulated in PTEN-knockdown neuronal cells. This effect was dependent on the lipid phosphatase activity of PTEN. Moreover, MOB1 was found to be a novel substrate for GSK3β that is phosphorylated on serine 146 and degraded via the ubiquitin–proteasome system (UPS). Finally, in vivo lentiviral-mediated silencing of PTEN promoted neurite outgrowth and functional recovery after SCI and this effect was reversed by down-regulation of MOB1. Taken together, this study provided mechanistic insight into how MOB1 acts as a novel and a necessary regulator in PTEN–GSK3β axis that controls neurite outgrowth after SCI.
引用
收藏
页码:4445 / 4464
页数:19
相关论文
共 50 条
  • [31] Inhibition of miR-129 Improves Neuronal Pyroptosis and Cognitive Impairment Through IGF-1/GSK3β Signaling Pathway: An In Vitro and In Vivo Study
    Feng Wang
    Lu Wang
    Guanghong Sui
    Caixia Yang
    Mengtian Guo
    Xiangyang Xiong
    Zheng Chen
    Qiang Zhang
    Ping Lei
    Journal of Molecular Neuroscience, 2021, 71 : 2299 - 2309
  • [32] Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer
    Gao, Fei
    Huang, Wei
    Zhang, YuQin
    Tang, ShaoHui
    Zheng, Lin
    Ma, Feng
    Wang, YiMing
    Tang, Hui
    Li, Xin
    ONCOTARGET, 2015, 6 (36) : 38667 - 38680
  • [33] PrPC negatively controls neuronal GSK3β and serotonin 1B receptor via a caveolin-Lyn complex
    Hirsch, Theo Z.
    Hernandez-Rapp, Julia
    Martin-Lanneree, Severine
    Pradines, Elodie
    Alleaume-Butaux, Aurelie
    Schneider, Benoit
    Baudry, Anne
    Launay, Jean-Marie
    Mouillet-Richard, Sophie
    PRION, 2014, 8 : 44 - 45
  • [34] Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo
    Reinhardt, Lydia
    Kordes, Susanne
    Reinhardt, Peter
    Glatza, Michael
    Baumann, Matthias
    Drexler, Hannes C. A.
    Menninger, Sascha
    Zischinsky, Gunther
    Eickhoff, Jan
    Froeb, Claudia
    Bhattarai, Prabesh
    Arulmozhivarman, Guruchandar
    Marrone, Lara
    Janosch, Antje
    Adachi, Kenjiro
    Stehling, Martin
    Anderson, Eric N.
    Abo-Rady, Masin
    Bickle, Marc
    Pandey, Udai Bhan
    Reimer, Michell M.
    Kizil, Caghan
    Schoeler, Hans R.
    Nussbaumer, Peter
    Klebl, Bert
    Sterneckert, Jared L.
    STEM CELL REPORTS, 2019, 12 (03): : 502 - 517
  • [35] In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183
    Schrecengost, Randy S.
    Green, Cecelia L.
    Zhuang, Yan
    Keller, Staci N.
    Smith, Ryan A.
    Maines, Lynn W.
    Smith, Charles D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (01): : 107 - 116
  • [36] Sis-25, a meroditerpenoid derivative with a cyclobutane scaffold, inhibits activated T cell proliferation by targeting GSK3β in vitro and in vivo
    Liu, Yang
    Li, Xingren
    Wu, Xiuyin
    Luo, Xingyan
    Yan, Bingchao
    Mo, Chunfen
    Guo, Huijie
    Yang, Shuxia
    Wang, Yantang
    Lai, Yi
    Puno, Pematenzin
    Li, Limei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 929
  • [37] Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3β-ULK1 axis
    Feng, Zuxi
    Ou, Yanghuan
    Deng, Xueqiang
    Deng, Minghao
    Yan, Xiaohua
    Chen, Leifeng
    Zhou, Fan
    Hao, Liang
    CELL AND BIOSCIENCE, 2024, 14 (01):
  • [38] GOLM1 facilitates human colorectal cancer progression and metastasis via activating the AKT/GSK3?/EMT axis
    Mao, Zonglei
    Wu, Yong
    Yao, Pingan
    Xing, Chungen
    NEOPLASMA, 2023, 70 (01) : 136 - 144
  • [39] SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
    Dai, Shuang
    Yan, Yuanliang
    Xu, Zhijie
    Zeng, Shuangshuang
    Qian, Long
    Huo, Lei
    Li, Xuejun
    Sun, Lunquan
    Gong, Zhicheng
    FRONTIERS IN PHARMACOLOGY, 2018, 8
  • [40] Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma
    Ito, Hiroshi
    Watari, Kosuke
    Shibata, Tomohiro
    Miyamoto, Tomofumi
    Murakami, Yuichi
    Nakahara, Yukiko
    Izumi, Hiroto
    Wakimoto, Hiroaki
    Kuwano, Michihiko
    Abe, Tatsuya
    Ono, Mayumi
    CANCER RESEARCH, 2020, 80 (02) : 234 - 248